The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
Y. Liu, N. Arase, J.-i. Kishikawa, M. Hirose, S. Li, A. Tada, S. Matsuoka, A. Arakawa, K. Akamatsu, C. Ono, H. Jin, K. Kishida, W. Nakai, M. Kohyama, A. Nakagawa, , H. Arase
The paper shows the Delta variant can escape NTD antibodies and gain infectivity when specific RBD mutations are present, suggesting the need for updated vaccines.
bioRxiv · Aug 22, 2021 · PreprintMicrobiology